Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Clinical Pharmacology and Therapeutics|October 1, 2020
Model-Based Cellular Kinetic Analysis of Chimeric Antigen Receptor-T Cells in HumansCan Liu, Vivaswath S Ayyar, Xirong Zheng, et al.
Clinical Pharmacology and Therapeutics|May 15, 2026
Model-Informed Dosing Strategies for Epcoritamab Monotherapy in Relapsed or Refractory Large B-Cell LymphomaXiaozhi Liao, Tommy Li, Steven Xu, et al.
Nature Biomedical Engineering|April 7, 2019
Depletion of PD-1-positive cells ameliorates autoimmune diseasePeng Zhao, Peng Wang, Shuyun Dong, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 23, 2022
A PBPK model recapitulates early kinetics of anti-PEG antibody-mediated clearance of PEG-liposomesAnne M Talkington, Morgan D McSweeney, Timothy Wessler, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 21, 2024
Chelator boosted tumor-retention and pharmacokinetic properties: development of 64Cu labeled radiopharmaceuticals targeting neurotensin receptorTao Zhang, Xinrui Ma, Muyun Xu, et al.
Clinical Pharmacology and Therapeutics|September 19, 2024
Industry Perspective on First-in-Human and Clinical Pharmacology Strategies to Support Clinical Development of T-Cell Engaging Bispecific Antibodies for Cancer TherapyPrathap Nagaraja Shastri, Nirav Shah, Martin Lechmann, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 28, 2019
Overcoming anti-PEG antibody mediated accelerated blood clearance of PEGylated liposomes by pre-infusion with high molecular weight free PEGMorgan D McSweeney, Lauren S L Price, Timothy Wessler, et al.
Clinical Pharmacology and Therapeutics|June 5, 2025
Using Quantitative Approaches to Optimize Dosages for New Combinations and Subsequent Indications for Oncology DrugsWei Gao, Jiang Liu, Cynthia J Musante, et al.
Pageof 8